Search - tctmd.com

Displaying 21 - 37 of 37

Sort: Relevancy | Date

News Industry News

NATEC Medical Ltd and US Endovascular Collaborate to Deliver a Brand New PTA Generation to the Peripheral US Market

September 15, 2014

News Industry News

Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

August 28, 2014

News Industry News

Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia

July 30, 2014

News Industry News

CardioDx Announces Aetna and Coventry Health Coverage for Corus® CAD Gene Expression Test

July 07, 2014

News Industry News

Mounting Scientific Evidence Supports Role of Power Plate® Whole Body Vibration in Lowering Blood Pressure

May 15, 2014

News Industry News

Sanofi and Regeneron To Present Alirocumab Clinical Data at the American College of Cardiology's 63rd Annual Scientific Session

March 27, 2014

News Industry News

Boston Scientific Launches Guidezilla™ Guide Extension Catheter in U.S. and Europe

July 12, 2013

News Industry News

Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold

June 11, 2013

News Industry News

Boston Scientific Launches Emerge™ PTCA Balloon Dilatation Catheter in the U.S.

September 27, 2012

News Industry News

Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries

May 16, 2012

News Industry News

Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter

April 30, 2012

News Industry News

Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study

February 07, 2012

News Industry News

Resverlogix Expands Phase 2b Program with the Commencement of Dosing in SUSTAIN

September 27, 2011

News Industry News

Medtronic Resolute® Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease

May 18, 2011

News Industry News

Medtronic Advances Research on Peripheral Devices, Highlights Upcoming Presentations

May 16, 2011

News Industry News

Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar

January 18, 2011

News Industry News

Merck Statement on Changes to Clinical Studies of Vorapaxar

January 12, 2011

Advertisement

NATEC Medical Ltd and US Endovascular Collaborate to Deliver a Brand New PTA Generation to the Peripheral US Market

Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia

CardioDx Announces Aetna and Coventry Health Coverage for Corus® CAD Gene Expression Test

Mounting Scientific Evidence Supports Role of Power Plate® Whole Body Vibration in Lowering Blood Pressure

Sanofi and Regeneron To Present Alirocumab Clinical Data at the American College of Cardiology's 63rd Annual Scientific Session

Boston Scientific Launches Guidezilla™ Guide Extension Catheter in U.S. and Europe

Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold

Boston Scientific Launches Emerge™ PTCA Balloon Dilatation Catheter in the U.S.

Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries

Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter

Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study

Resverlogix Expands Phase 2b Program with the Commencement of Dosing in SUSTAIN

Medtronic Resolute® Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease

Medtronic Advances Research on Peripheral Devices, Highlights Upcoming Presentations

Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar

Merck Statement on Changes to Clinical Studies of Vorapaxar

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content